Turkish
 
Home Page
Online Submission
Recent Issue
Archive
About
Instructions for Authors
Articles in Press
Editorial Board
Contact
  

Keyword

Title

Summary



   
Depression and Anxiety in Spondyloarthritis: Prevalence and Relationship with Clinical Parameters and Self-Reported Outcome Measures

Aicha BEN TEKAYA, Ines MAHMOUD, Ines HAMDI, Safouene HECHMI,Olfa SAIDANE, Rawdha TEKAYA, Leila ABDELMOULA
2019 30(2): 90-98
[Back]    [Full Text (PDF)]    [E-Mail to Author]
Objective: To assess the prevalence of depression and anxiety among
patients with spondyloarthritis.
Method: One hundred patients with spondyloarthritis attending the
rheumatology outpatient unit were enrolled. Duration of morning
stiffness, pain/fatigue visual-analogue-scale, Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI), Functional Index, Metrology
Index, Patient Global Score, Hospital Anxiety and Depression Scale
(HADS) including depression subscale (HADS-D) and anxiety
subscale (HADS-A), Ankylosing Spondylitis Quality of Life (ASQoL)
Scale, Short Form 36 Health Survey and Functional Assessment of
Chronic Illness Therapy-Fatigue-Scale were used to assess clinical and
psychological status.
Results: The HADS-D and HADS-A scores revealed that 31% of the
patients were depressed and 39% had anxiety. Multivariate logistic
regression analysis revealed that a VAS fatigue >50, morning stiffness
>15minutes, BASDAI >4, BASFI >4, BAS-G >50 and high FACITFatigue
scale were independent risk factors associated with the risk
of both depression and anxiety. A visual-analogue-scale pain >50
was an independent risk factor for only depression. Female gender,
disadvantaged social class and MCS <50 seemed to be the independent
risk factors associated only with anxiety.
Conclusion: Association of SpA with anxiety and/or depression appear
multifactorial including both personal and disease-related factors.
Early identification of depressive and anxiety disorders may allow
early referral for psychiatric assessment, educational programs and
psychopharmacological treatment.